Loading...
XMEX
MEDICAB
Market cap347mUSD
Dec 05, Last price  
57.24MXN
1D
4.07%
1Q
27.20%
Jan 2017
35.32%
Name

Medica Sur, S.A.B. De C.V.

Chart & Performance

D1W1MN
XMEX:MEDICAB chart
P/E
13.69
P/S
1.43
EPS
4.18
Div Yield, %
2.62%
Shrs. gr., 5y
-2.73%
Rev. gr., 5y
3.55%
Revenues
4.40b
+6.61%
1,057,251,0981,224,235,6481,397,174,4901,556,154,7551,784,449,4111,822,723,9751,900,834,0932,089,975,6842,256,399,6122,292,095,9952,278,751,6022,590,272,6123,431,445,8463,607,605,8393,698,067,6774,466,185,9343,906,143,7753,867,922,4284,129,753,9844,402,820,000
Net income
462m
-27.32%
144,495,381194,246,154216,324,806193,732,240236,829,900231,326,985224,088,054300,513,456379,765,048349,084,341241,018,529142,634,010231,798,220169,295,459140,551,783558,827,8221,154,516,740949,802,530634,983,587461,509,000
CFO
595m
+40.34%
230,752,691311,868,812305,416,639306,190,243427,755,325316,393,450349,721,873344,107,405494,095,240474,579,657327,807,240198,782,141213,985,864305,898,124425,440,5801,101,315,918821,320,259270,090,208423,871,328594,873,000
Dividend
May 14, 20241.5 MXN/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Médica Sur, S.A.B. de C.V. operates as a healthcare institution in Mexico. The company offers bypass and gastric banding, cholecystectomy, inguinal hernia repair, liposculpture, breast cosmetic, stereotactic radio, hip arthroplasty, knee arthroscopy, shoulder arthroscopy, spine, lithiasis, radical prostatectomy, and prostate surgeries. It also provides radiotherapy, imaging, and checkup services, as well as medical insurance services. The company was incorporated in 1966 and is based in Mexico City, Mexico. Médica Sur, S.A.B. de C.V. is a subsidiary of Neuco, SA de CV.
URL
https://www.medicasur.com.mx/
IPO date
Mar 10, 1994
Employees
Domiciled in
MX
Incorporated in
MX

Valuation

Title
MXN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT